Paul Toren

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Venues

The Journal of urology

Communications medicine

BJU international

The Prostate

CHU de Québec-Université Laval Research Centre (Oncology Division), Université Laval Cancer Research Centre

University of British Columbia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CHU de Québec-Université Laval Research Centre (Oncology Division), Université Laval Cancer Research Centre Sep 01 2015

Canada

Assistant Professor :: Surgery

Education History

University of British Columbia Sep 01 2013 - Feb 17 2017

Canada

PHD :: Experimental Medicine

Publications

Karine Robitaille, Marie-Hélène Guertin, Afshin Jamshidi, Hui Wen Xu, Hélène Hovington, Jean-François Pelletier, Lisanne Beaudoin, Nikunj Gevariya, Louis Lacombe, Rabi Tiguert, Yves Caumartin, Thierry Dujardin, Paul Toren, Michele Lodde, Étienne Racine, Dominique Trudel, Martine Perigny, Thierry Duchesne, Josée Savard, Pierre Julien, Yves Fradet, Vincent Fradet
A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation. Communications medicine 4 (1) (2024)
Karine Robitaille, Marie-Hélène Guertin, Afshin Jamshidi, Hui Wen Xu, Hélène Hovington, Jean-François Pelletier, Lisanne Beaudoin, Nikunj Gevariya, Louis Lacombe, Rabi Tiguert, Yves Caumartin, Thierry Dujardin, Paul Toren, Michele Lodde, Étienne Racine, Dominique Trudel, Martine Perigny, Thierry Duchesne, Josée Savard, Pierre Julien, Yves Fradet, Vincent Fradet
A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation. Communications medicine 4 (1) (2024)
Paul Toren, Anna Wilkins, Keval Patel, Amy Burley, Typhaine Gris, Roger Kockelbergh, Taha Lodhi, Ananya Choudhury, Richard T Bryan
The sex gap in bladder cancer survival - a missing link in bladder cancer care? Nature reviews. Urology (2023)
Josée Savard, Hanane Moussa, Jean-François Pelletier, Pierre Julien, Louis Lacombe, Rabi Tiguert, Yves Caumartin, Thierry Dujardin, Paul Toren, Frédéric Pouliot, Michele Lodde, Yves Fradet, Karine Robitaille, Vincent Fradet
Effects of omega-3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double-blind placebo-controlled randomized trial. Cancer medicine (2023)
Clovis Boibessot, Oscar Molina, Gabriel Lachance, Christophe Tav, Audrey Champagne, Bertrand Neveu, Jean-François Pelletier, Frédéric Pouliot, Vincent Fradet, Steve Bilodeau, Yves Fradet, Alain Bergeron, Paul Toren
Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor-associated macrophage phenotype. Clinical and translational medicine 12 (1) (2022)
Samuel Tremblay, Lily Summers-Trasiewicz, Frédéric Pouliot, Juanita M Crook, Keyue Ding, Laurence H Klotz, Paul Toren
Reply by Authors. The Journal of urology 206 (5) (2021)
Samuel Tremblay, Lily Summers-Trasiewicz, Frédéric Pouliot, Juanita M Crook, Keyue Ding, Laurence H Klotz, Paul Toren
Interpreting Testosterone and Concomitant Prostate Specific Antigen Values during Androgen Deprivation Therapy for Recurrent Prostate Cancer. The Journal of urology 206 (5) (2021)
Paul Toren, Hervé Brisson, David Simonyan, Hélène Hovington, Louis Lacombe, Alain Bergeron, Yves Fradet
Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival. World journal of urology 39 (5) (2020)
France-Hélène Joncas, Fabrice Lucien, Mélanie Rouleau, Fannie Morin, Hon Sing Leong, Frédéric Pouliot, Yves Fradet, Caroline Gilbert, Paul Toren
Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients. The Prostate 79 (15) (2019)
Paul Toren, Azik Hoffman, Keyue Ding, France-Hélène Joncas, Véronique Turcotte, Patrick Caron, Frédéric Pouliot, Yves Fradet, Éric Lévesque, Chantal Guillemette, Laurence Klotz
Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A Post Hoc Analysis of the PR.7 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (21) (2018)
Vincent Fradet, Paul Toren, Molière Nguile-Makao, Michele Lodde, Jérome Lévesque, Caroline Léger, André Caron, Alain Bergeron, Tal Ben-Zvi, Louis Lacombe, Frédéric Pouliot, Rabi Tiguert, Thierry Dujardin, Yves Fradet
Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors. BJU international 121 (3) (2017)

Paul Toren.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Paul Toren